The Acknowledgements section in this Article is incomplete.
“We thank Dr. Robert Friesel for critical reading of the manuscript. We thank MMCRI histology core Armie Mangoba, Katrina Abramo and Dr. Volkhard Lindner for creating breast cancer tissue array (TMA) and histochemistry analysis. We thank MMC BioBank Robert Ackroyd, Dr. Ivette F. Emery and Dr. Anne Breggia for coordinating studies on clinical specimens. This study was supported by the Maine Cancer Foundation Accelerate Grant and a Maine Medical Center Research Program Grant to X.Y”.
Should read:
“We thank Dr. Robert Friesel for critical reading of the manuscript. We thank MMCRI histology core Armie Mangoba, Katrina Abramo and Dr. Volkhard Lindner for creating breast cancer tissue array (TMA) and histochemistry analysis. We thank MMC BioBank Robert Ackroyd, Dr. Ivette F. Emery and Dr. Anne Breggia for coordinating studies on clinical specimens. This study was supported by the Maine Cancer Foundation Accelerate Grant and a Maine Medical Center Research Program Grant to X.Y. This work was supported by a grant from the Maine Cancer Foundation and NIH grants P30 GM1033465 (molecular phenotyping, histopathology, and progenitor cell analysis cores) to D. Wojchowski, PI, and P30 GM103392 (Histopathology and cell imaging cores) to R. Friesel, PI, and generous support from the Maine Medical Center”.
Additional information
The online version of the original article can be found at 10.1038/srep23216
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
He, Q., Jing, H., Liaw, L. et al. Correction: Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype. Sci Rep 7, 46791 (2017). https://doi.org/10.1038/srep46791
Published:
DOI: https://doi.org/10.1038/srep46791
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
